"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
| Descriptor ID |
D003362
|
| MeSH Number(s) |
N03.219.151.125
|
| Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 8 | 8 |
| 2001 | 1 | 6 | 7 |
| 2002 | 0 | 6 | 6 |
| 2003 | 0 | 9 | 9 |
| 2004 | 1 | 6 | 7 |
| 2005 | 1 | 9 | 10 |
| 2006 | 0 | 10 | 10 |
| 2007 | 1 | 15 | 16 |
| 2008 | 0 | 11 | 11 |
| 2009 | 0 | 8 | 8 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 10 | 10 |
| 2012 | 0 | 15 | 15 |
| 2013 | 0 | 13 | 13 |
| 2014 | 3 | 14 | 17 |
| 2015 | 5 | 23 | 28 |
| 2016 | 3 | 23 | 26 |
| 2017 | 7 | 21 | 28 |
| 2018 | 5 | 18 | 23 |
| 2019 | 3 | 23 | 26 |
| 2020 | 7 | 23 | 30 |
| 2021 | 2 | 18 | 20 |
| 2022 | 1 | 11 | 12 |
| 2023 | 0 | 13 | 13 |
| 2024 | 7 | 9 | 16 |
| 2025 | 4 | 17 | 21 |
| 2026 | 2 | 8 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
Cost-Effectiveness of a Blended Learning Training Approach for Health Care Workers Conducting HIV Index Case Testing in Malawi: Secondary Economic Analysis of a Cluster-Randomized Controlled Trial. JMIR Med Educ. 2026 08 27; 12:e95450.
-
Cost-Effectiveness of Endoscopic Bariatric Therapies Compared with Laparoscopic Sleeve Gastrectomy and Semaglutide. Obes Surg. 2026 Sep; 36(9):4669-4675.
-
Cost-effectiveness of HES V2.0 and GALAD for hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatol Commun. 2026 Aug 01; 10(8).
-
Estimating stage-specific lung cancer costs for economic evaluation of LDCT screening in Ireland: a patient-level microsimulation. BMC Health Serv Res. 2026 Jul 11; 26(1).
-
Economic evaluation of Hirschsprung disease testing strategies for children with medically-refractory chronic constipation: A cost-effectiveness analysis. J Pediatr Surg. 2026 Sep; 61(9):163279.
-
High Potency Proton Pump Inhibitor Versus Vonoprazan in Helicobacter pylori Triple Therapy. Helicobacter. 2026 Jul-Aug; 31(4):e70152.
-
Surgical Excision Versus Percutaneous Ultrasound-Guided Fenestration for Pediatric Ganglia: A Cost and Recurrence Rate Analysis. J Am Acad Orthop Surg. 2026 Aug 01; 34(15):e2092-e2096.
-
Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study. Prostate. 2026 08; 86(11):1233-1240.
-
The pro-doc-tivity pause: Health economic benefits of collegial connection. Ann Allergy Asthma Immunol. 2026 07; 137(1):101-106.e7.
-
Cost-Effectiveness of the I'm Ready HIV Self-Testing Programme Among High-Risk Populations in Canada. J Int AIDS Soc. 2026 Apr; 29(4):e70097.